| 2.8 |
8.5 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.7 |
6.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.6 |
2.3 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.6 |
1.7 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.5 |
1.5 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.5 |
3.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.4 |
3.4 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.3 |
2.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 |
4.1 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.3 |
0.8 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.2 |
2.0 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.2 |
1.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
1.8 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.2 |
0.7 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
0.6 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
1.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.4 |
GO:0036292 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) DNA rewinding(GO:0036292) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
0.6 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.5 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 |
0.7 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
1.3 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
1.6 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.3 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
1.8 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.5 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.6 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
1.9 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 |
0.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
1.3 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
2.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
2.7 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
2.2 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
1.6 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.5 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
1.7 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.5 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.4 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.5 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 |
0.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.9 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
